Robert Harrington to Evidence-Based Medicine
This is a "connection" page, showing publications Robert Harrington has written about Evidence-Based Medicine.
Connection Strength
1.478
-
Assessing research results in the medical literature: trust but verify. JAMA Intern Med. 2013 Jun 24; 173(12):1053-5.
Score: 0.345
-
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):708S-775S.
Score: 0.243
-
Randomized Trials Versus Common?Sense and Clinical Observation: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 08 04; 76(5):580-589.
Score: 0.141
-
Prehospital Phase of Acute Stroke Care: Guideline and Policy Considerations as Science and Evidence Rapidly Evolve. Stroke. 2019 07; 50(7):1637-1639.
Score: 0.130
-
Using Digital Health Technology to?Better?Generate Evidence and Deliver?Evidence-Based?Care. J Am Coll Cardiol. 2018 06 12; 71(23):2680-2690.
Score: 0.122
-
A 'green button' for using aggregate patient data at the point of care. Health Aff (Millwood). 2014 Jul; 33(7):1229-35.
Score: 0.093
-
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):776S-814S.
Score: 0.061
-
Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace? CMAJ. 2008 May 06; 178(10):1316-9.
Score: 0.060
-
Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics. Health Aff (Millwood). 2007 Jan-Feb; 26(1):62-74.
Score: 0.055
-
Should we routinely supplement coronary patients with folate therapy to prevent in-stent restenosis? Am Heart J. 2005 Jun; 149(6):1035-6.
Score: 0.049
-
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):513S-548S.
Score: 0.047
-
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c
View in: PubMed
Score: 0.035
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):e29-84.
Score: 0.020
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Catheter Cardiovasc Interv. 2012 Jun 01; 79(7):1023-82.
Score: 0.020
Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2005 Mar; 149(3):474-81.
Score: 0.012
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):549S-575S.
Score: 0.012
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):576S-599S.
Score: 0.012
Changing the model of care for patients with acute coronary syndromes. Am Heart J. 2003 Oct; 146(4):605-12.
Score: 0.011
Poverty, process of care, and outcome in acute coronary syndromes. J Am Coll Cardiol. 2003 Jun 04; 41(11):1948-54.
Score: 0.011